首页|期刊导航|口腔疾病防治|头颈肿瘤放疗后口腔微生态失调及其干预策略的研究进展

头颈肿瘤放疗后口腔微生态失调及其干预策略的研究进展OA

Research progress on oral microecological imbalance and intervention strategies after radiotherapy for head and neck tumors

中文摘要英文摘要

放射治疗(放疗)是头颈肿瘤的重要治疗手段之一,但在其杀伤肿瘤的同时会显著影响口腔微生态稳态,与放射性口腔黏膜炎等多种并发症密切相关.随着放疗剂量的累积与时间的延长,口腔菌群中链球菌属等的丰富度和多样性呈现下降趋势;但放疗同时会选择性地促进变形菌门、拟杆菌门等菌群的增殖,这些门类中富含多种条件致病菌.放疗通过激活核因子κB(NF-κB)通路诱发慢性炎症与氧化应激,损伤上皮屏障并抑制局部免疫,引起唾液腺等器官损伤,还可通过口腔-肠道轴引发全身性疾病,构成一个多层级、相互关联的致病网络.在干预方面,通过使用益生菌、益生元等口腔微生态调控措施,对放射性口腔黏膜炎等副反应显示出良好疗效.以唾液为载体的口腔菌群移植技术正逐渐兴起,并有望成为重建口腔微生态平衡的核心策略之一.现有干预手段为临床实践提供了初步路径,但该领域仍面临若干关键的科学问题:口腔微生态与全身性疾病的关联仍停留在相关性表面,缺乏因果性论证;口腔菌群移植的供体筛选标准、移植方案及长期安全性等关键参数尚未明确.因此,未来的研究应致力于开展大规模的临床试验,确立口腔微生态干预措施的标准化流程与安全性评价体系,探讨益生菌、益生元与菌群移植等联合治疗策略,推动个体化精准调控的发展,从而更有效地应对放疗所致口腔微生态失调,改善头颈肿瘤患者的治疗效果与生活质量.

Radiotherapy is a crucial treatment modality for head and neck tumors.However,while effectively killing tumor cells,it significantly disrupts the homeostasis of the oral microecology,which is closely associated with various complications such as radiation-induced oral mucositis.Literature review indicates that as radiotherapy doses accumu-late and treatment durations extend,the richness and diversity of the oral microbiota show a declining trend,with the genus Streptococcus decreasing most markedly.In contrast,radiotherapy selectively promotes the proliferation of bacte-rial phyla such as Proteobacteria and Bacteroidetes,which are rich in opportunistic pathogens.Mechanistically,radio-therapy activates the nuclear factor-kappa B pathway,triggering chronic inflammation and oxidative stress,damaging the epithelial barrier,suppressing local immunity,and causing damage to organs such as the salivary glands.It can also induce systemic diseases via the oral-gut axis,forming a multi-level,interconnected pathogenic network.In terms of in-terventions,treatment strategies including probiotics and prebiotics have shown promising efficacy against side effects such as radiation-induced oral mucositis.Saliva-based oral microbiota transplantation is an emerging strategy that is ex-pected to become widely utilized for restoring oral microecological balance.Existing interventions provide preliminary pathways for clinical practice,but this field still faces several key scientific questions.The association between oral mi-croecology and systemic diseases remains largely correlative,lacking causal evidence.Furthermore,critical parameters for oral microbiota transplantation,such as donor screening criteria,transplantation protocols,and long-term safety,are not yet well-defined.Therefore,future research should focus on conducting large-scale clinical trials to establish stan-dardized protocols and safety evaluation systems for oral microecological interventions,and explore combined treatment therapies such as probiotics,prebiotics,and microbiota transplantation to advance the development of personalized pre-cision modulation.These will enable more effective management of radiotherapy-induced oral microecological dysbiosis and improve treatment outcomes and quality of life for patients with head and neck tumors.

刘雪;李雨霏;杨薪瑶;李好;张爱琳;崔蕾;黄正蔚;侯黎莉

上海交通大学护理学院,上海(200025)上海交通大学护理学院,上海(200025)上海交通大学护理学院,上海(200025)上海交通大学医学院附属第九人民医院牙体牙髓科,上海(200011)上海交通大学护理学院,上海(200025)上海交通大学护理学院,上海(200025)上海交通大学医学院附属第九人民医院牙体牙髓科,上海(200011)上海市交通大学医学院附属第九人民医院护理部,上海(200011)

医药卫生

头颈肿瘤放射治疗放射性口腔黏膜病口腔微生态菌群失调益生菌益生元菌群移植口腔菌群精准调控

head and neck tumorradiotherapyradiation-induced oral mucosal diseaseoral microecologi-calmicroecology imbalanceprobioticsprebioticsmicrobiota transplantationoral microbiotaprecision modulation

《口腔疾病防治》 2026 (4)

385-394,10

国家自然科学基金项目(82071104)上海市重中之重研究中心(2022ZZ01017)上海市"科技创新行动计划"长三角科技创新共同体领域项目(21002411300)中国医学科学院医学与健康科技创新工程项目(2019-I2M-5-037) This study was supported by the grants from the National Natural Science Foundation of China(No.82071104)Shang-hai's Top Priority Research Center(No.2022ZZ01017)the Yangtze River Delta Science and Technology Innovation Community Project of the"Science and Technology Innovation Action Plan"in Shanghai(No.21002411300)Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(No.2019-I2M-5-037).

10.12016/j.issn.2096-1456.202550349

评论